Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer

Journal of Gastroenterology and Hepatology (Australia) - Tập 24 Số 3 - Trang 469-474 - 2009
Chan Gyoo Kim1, Il Ju Choi2, Jong Yeul Lee2, Soo‐Jeong Cho2, Byung–Ho Nam3, Myeong‐Cherl Kook2, Eun Kyung Hong2, Young‐Woo Kim2
1Research Institute and Hospital, National Cancer Center, Ilsandong-gu, Goyang, Gyeonggi, Korea.
2Research Institute and Hospital and
3Center for Clinical Trials, National Cancer Center, Ilsandong‐gu, Goyang, Gyeonggi, Korea

Tóm tắt

AbstractBackground:  Helicobacter pylori eradication is recommended in post‐gastric cancer resection, but premalignant changes may prevent the detection of H. pylori. The aim of this study was to determine appropriate biopsy site for detecting H. pylori in gastric cancer patients.Materials and Methods:  Consecutive patients (194) with gastric adenocarcinoma were prospectively enrolled. Helicobacter pylori was evaluated by serology, histology and rapid urease test. Biopsy sites included antrum lesser curvature, upper body lesser curvature (UBLC) and upper body greater curvature (UBGC). Two biopsy specimens were obtained from each site for histological examination. One additional specimen was obtained from UBGC for the rapid urease test.Results:  The overall infection rate of H. pylori was 84.0% (95% CI 78.9–89.2). The sensitivity of histology for detecting H. pylori at various sites was: antrum (54.9%; 95% CI 45.7–63.9), UBLC (80.3%; 95% CI 72.2–87.0) and UBGC (95.1%; 95% CI 89.6–98.2). Specificities of all three biopsy sites were more than 95%. Sensitivity and specificity of the rapid urease test performed at UBGC were 96% and 100%, respectively. Sensitivities of histology decreased in correlation with increasing severity of atrophy and intestinal metaplasia (both P < 0.001 using the chi‐square test for trend). The proportions of moderate to marked atrophy/intestinal metaplasia at UBGC (12.8%/14.7%) were significantly lower than those at antrum (50.0%/57.8%, P < 0.001 respectively) or UBLC (40.0%/48.9%, P < 0.001 respectively).Conclusions:  The UBGC side is the most sensitive and specific biopsy site to detect H. pylori in gastric cancer patients due to less frequent atrophy and intestinal metaplasia than at the antrum or UBLC side.

Từ khóa


Tài liệu tham khảo

International Agency for Research on Cancer, 1994, Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994, IARC Monogr. Eval. Carcinog. Risks. Hum., 61, 1

10.1136/gut.2006.101634

10.1111/j.1572-0241.2007.01393.x

10.1046/j.1523-5378.2003.00168.x

10.1046/j.1365-2036.17.s2.6.x

10.1097/00000478-199610000-00001

10.1016/S0016-5107(94)70067-2

10.1111/j.1523-5378.1996.tb00048.x

Bermejo F, 2002, Rapid urease test utility for Helicobacter pylori infection diagnosis in gastric ulcer disease, Hepatogastroenterology, 49, 572

Correa P, 1988, A human model of gastric carcinogenesis, Cancer Res., 48, 3554

10.1016/0016-5085(91)90474-Y

10.1053/gast.1996.v111.pm8898634

10.1111/j.1572-0241.1998.166_b.x

10.1016/S0046-8177(99)90303-9

10.1097/00042737-200402000-00012

10.1002/(SICI)1098-2825(1999)13:4<194::AID-JCLA9>3.0.CO;2-E

Eom HS, 2001, Evaluation of four commercial enzyme immunoassay for detection of Helicobacter pylori infection, Korean J. Gastroenterol., 37, 312

10.1016/0016-5085(95)90278-3

10.1097/00042737-199806000-00007

10.1016/S0895-4356(99)00222-X

Dursun M, 2004, Evaluation of optimal gastric mucosal biopsy site and number for identification of Helicobacter pylori, gastric atrophy and intestinal metaplasia, Hepatogastroenterology, 51, 1732

10.1046/j.1440-1746.2000.02240.x

10.3748/wjg.v11.i6.791

10.1136/gut.35.10.1372

10.1016/S0140-6736(95)91084-0

Kawaguchi H, 1996, Helicobacter pylori infection is the major risk factor for atrophic gastritis, Am. J. Gastroenterol., 91, 959

Correa P, 1995, Helicobacter pylori and gastric carcinogenesis, Am. J. Surg. Pathol., 19, S37

10.1034/j.1600-0463.2003.1110604.x

10.1016/S0016-5085(19)33241-X

10.1111/j.1572-0241.2000.02074.x

10.1046/j.1365-2036.16.s2.17.x

10.1056/NEJM199110173251603

10.1136/bmj.302.6788.1302

10.1016/0140-6736(93)90938-D

10.1111/j.1572-0241.1999.01360.x

10.1111/j.1365-2036.2004.02075.x

10.3748/wjg.v11.i9.1387

10.1001/jama.291.2.187

10.1158/1055-9965.EPI-05-0931

Kokkola A, 2001, Gastric carcinoma in young adults, Hepatogastroenterology, 48, 1552

10.1136/gut.2007.137364